Vanda Pharmaceuticals Inc. VNDA announced that the FDA has approved its marketed drug, Fanapt (iloperidone), for a new indication. The regulatory body has now approved Fanapt tablets for the acute ...
An antipsychotic approved by the FDA in 2009 to treat schizophrenia has now been green-lighted for use in bipolar 1 disorder. Iloperidone (Fanapt) is now FDA-approved for adults with bipolar 1 ...
WASHINGTON, April 2, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Fanapt ® (iloperidone) tablets ...
The US Food and Drug Administration (FDA) has approved iloperidone tablets (Fanapt) for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Iloperidone is a ...
BioWorld - Saturday, July 5, 2025 See today's BioWorld Home » Vanda Shares Surge 626% on FDA Approval of Fanapt To read the full story, subscribe or sign in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results